Hybrid Systems: Combining Niosomes/Proniosomes With Other Nanocarriers For Multi-Functional Delivery

Hybrid nanocarrier systems that integrate niosomes or proniosomes with complementary nanoscale delivery platforms have emerged as a promising strategy to overcome the limitations of single-carrier approaches. Niosomes and proniosomes are values for their biocompatibility, chemical stability and ability to encapsulate both hydrophilic and lipophilic drugs; however, their therapeutic performance can be further enhanced when combined with other nanocarriers such as nanoparticles, nanoemulsions, liposomes, polymeric micelles, dendrimers, or hydrogels. These hybrid systems are specifically engineered to provide multi-functional delivery, enabling controlled release, improved penetration, enhanced stability, and targeted site-specific action. The synergistic design of such hybrids allows researchers to tailor surface properties, drug- loading capacity, and responsiveness to physiological triggers. For examples, embedding niosomes within polymeric nanopraticles enhances mechanical strength and sustained release, while integrating them into hydrogel networks improves muco-adhesion and localized delivery. Similarly, combing proniosomes with metallic or polymeric nanocarriers can facilitate stimuli-responsive behaviour, imaging-guided therapy, and co-delivery of multiple therapeutic agents. These advancements are especially relevant in treating chronic diseases, cancer, dermatological disorders, and infections where multi-layered therapeutic actions are required. Overall, hybrid systems represent a next-generation advancement in drug delivery technology, offering improved pharmacokinetics, superior therapeutic outcomes, and customizable functionalities. Continued research into fabrication techniques, stability optimization and safety evaluation will be crucial in translating these innovative platforms into clinically relevant products.